銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城

Fabtech Technologies, which provides turnkey engineering solutions to the biopharma, pharmaceutical, and healthcare sectors, has launched its ?230.35 crore Initial Public Offering (IPO) today, September 29, 2025.??
Ahead of the IPO opening, the company has raised ?7.89 crore from anchor investors on September 26, 2025.?
Fabtech Technologies IPO is a book-building issue of ?230.35 crores, consisting entirely of a fresh issue of 1.21 crore shares.?
The price band is set between ?181 and ?191 per share. The basis of allotment will be finalised by October 3, 2025, and the tentative listing date on BSE and NSE is October 7, 2025.?
[29-September-2025 17:00:00]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.77 |
|
Non-Institutional Investors |
0.46 |
|
Retail Individual Investors (RIIs) |
0.70 |
|
Employees |
0.54 |
|
Total |
0.70 |
The net proceeds from the fresh will be used to:
Fabtech Technologies is a globally established provider of turnkey engineering solutions to the pharmaceutical, biotechnology, and healthcare sectors. The company has a strong international presence across more than 62 countries and delivers end-to-end turnkey solutions for setting up aseptic manufacturing facilities.?
Beyond full-scale turnkey projects, Fabtech also offers standalone engineering solutions, particularly in equipment procurement, supply, and logistics management.?
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here